Yale established the first university-based department of clinical pharmacology and chemotherapy in the US
In 1965, Yale established the first university-based department of clinical pharmacology and chemotherapy in the United States (the…
In 1965, Yale established the first university-based department of clinical pharmacology and chemotherapy in the United States (the…
In 1963, the National Cancer Institute initiated a pilot study to test MOPP (Mechlorethamine, Vincristine, Procarbazine, Prednisone) chemotherapy…
In 1958, NCI scientists pioneer the use of combination chemotherapy. Partial and complete remissions, as well as prolonged…
In 1957, Roy Hertz and Min Chiu Li achieve the first completed cure of a human solid tumor…
On Apr. 1, 1955, the National Cancer Institute’s Cancer Chemotherapy National Service Center was established in the institute…
On Dec. 7, 1953, the U.S. Food and Drug Administration (FDA) approved methotrexate, an antimetabolite derived from folic…
In 1953, Yale established the first pharmacology department in the U.S. to focus on cancer chemotherapy and cancer…
In 1947, biochemist Yellapragada SubbaRow co-discovered the first cancer chemotherapy agent for children suffering from acute leukemia. He…
On Jul. 1, 1946, the National Cancer Institute cancer control program was established with appropriations to the states…
On Aug. 27, 1942, chemotherapy was first used to treat a cancer patient and the beginning of its…
In 1942, the first intravenous chemotherapy treatment of a cancer patient was performed at Yale.